BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7905703)

  • 1. Alleviation of catecholamine inhibition of tyrosine hydroxylase by phosphorylation at serine40.
    Daubner SC; Fitzpatrick PF
    Adv Exp Med Biol; 1993; 338():87-92. PubMed ID: 7905703
    [No Abstract]   [Full Text] [Related]  

  • 2. Site-directed mutagenesis of serine 40 of rat tyrosine hydroxylase. Effects of dopamine and cAMP-dependent phosphorylation on enzyme activity.
    Daubner SC; Lauriano C; Haycock JW; Fitzpatrick PF
    J Biol Chem; 1992 Jun; 267(18):12639-46. PubMed ID: 1352289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-directed mutagenesis of tyrosine hydroxylase. Role of serine 40 in catalysis.
    Wu J; Filer D; Friedhoff AJ; Goldstein M
    J Biol Chem; 1992 Dec; 267(36):25754-8. PubMed ID: 1361189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of substitution at serine 40 of tyrosine hydroxylase on catecholamine binding.
    McCulloch RI; Daubner SC; Fitzpatrick PF
    Biochemistry; 2001 Jun; 40(24):7273-8. PubMed ID: 11401575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of the MAP kinase ERK2 for phosphorylation of tyrosine hydroxylase.
    Royo M; Daubner SC; Fitzpatrick PF
    Arch Biochem Biophys; 2004 Mar; 423(2):247-52. PubMed ID: 15001389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of phosphorylation of serine 40 of tyrosine hydroxylase on binding of catecholamines: evidence for a novel regulatory mechanism.
    Ramsey AJ; Fitzpatrick PF
    Biochemistry; 1998 Jun; 37(25):8980-6. PubMed ID: 9636040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytic domain surface residues mediating catecholamine inhibition in tyrosine hydroxylase.
    Briggs GD; Bulley J; Dickson PW
    J Biochem; 2014 Mar; 155(3):183-93. PubMed ID: 24334288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of the blue-green rat phaeochromocytoma (PC12) tyrosine hydroxylase with a dopamine-Fe(III) complex. Reversal of the endogenous feedback inhibition by phosphorylation of serine-40.
    Andersson KK; Vassort C; Brennan BA; Que L; Haavik J; Flatmark T; Gros F; Thibault J
    Biochem J; 1992 Jun; 284 ( Pt 3)(Pt 3):687-95. PubMed ID: 1352446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of regulatory serines of rat tyrosine hydroxylase to glutamate: effects on enzyme stability and activity.
    Royo M; Fitzpatrick PF; Daubner SC
    Arch Biochem Biophys; 2005 Feb; 434(2):266-74. PubMed ID: 15639226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of N-terminus-deleted human tyrosine hydroxylase type 1 by end products of catecholamine biosynthetic pathway.
    Ota A; Yoshida S; Nagatsu T
    J Neural Transm (Vienna); 1996; 103(12):1415-28. PubMed ID: 9029408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine inhibition of human tyrosine hydroxylase type 1 is controlled by the specific portion in the N-terminus of the enzyme.
    Nakashima A; Mori K; Suzuki T; Kurita H; Otani M; Nagatsu T; Ota A
    J Neurochem; 1999 May; 72(5):2145-53. PubMed ID: 10217296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous tetrahydroisoquinolines associated with Parkinson's disease mimic the feedback inhibition of tyrosine hydroxylase by catecholamines.
    Scholz J; Toska K; Luborzewski A; Maass A; Schünemann V; Haavik J; Moser A
    FEBS J; 2008 May; 275(9):2109-21. PubMed ID: 18355318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysine241 of tyrosine hydroxylase is not required for binding of tetrahydrobiopterin substrate.
    Daubner SC; Fitzpatrick PF
    Arch Biochem Biophys; 1993 May; 302(2):455-60. PubMed ID: 8098196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinol activates tyrosine hydroxylase acutely by increasing the phosphorylation of serine40 and then serine31 in bovine adrenal chromaffin cells.
    Gelain DP; Moreira JC; Bevilaqua LR; Dickson PW; Dunkley PR
    J Neurochem; 2007 Dec; 103(6):2369-79. PubMed ID: 17908239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited proteolysis of tyrosine hydroxylase identifies residues 33-50 as conformationally sensitive to phosphorylation state and dopamine binding.
    McCulloch RI; Fitzpatrick PF
    Arch Biochem Biophys; 1999 Jul; 367(1):143-5. PubMed ID: 10375411
    [No Abstract]   [Full Text] [Related]  

  • 16. Kinetics of regulatory serine variants of tyrosine hydroxylase with cyclic AMP-dependent protein kinase and extracellular signal-regulated protein kinase 2.
    Royo M; Colette Daubner S
    Biochim Biophys Acta; 2006 Apr; 1764(4):786-92. PubMed ID: 16503426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-level expression of rat PC12 tyrosine hydroxylase cDNA in Escherichia coli: purification and characterization of the cloned enzyme.
    Wang YH; Citron BA; Ribeiro P; Kaufman S
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8779-83. PubMed ID: 1681542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of mouse tyrosine hydroxylase in Escherichia coli.
    Ichikawa S; Nasrin S; Nagatsu T
    Biochem Biophys Res Commun; 1991 Jul; 178(2):664-71. PubMed ID: 1677565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of phosphorylation by protein kinase A on binding of catecholamines to the human tyrosine hydroxylase isoforms.
    Sura GR; Daubner SC; Fitzpatrick PF
    J Neurochem; 2004 Aug; 90(4):970-8. PubMed ID: 15287903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural mechanism for tyrosine hydroxylase inhibition by dopamine and reactivation by Ser40 phosphorylation.
    Bueno-Carrasco MT; Cuéllar J; Flydal MI; Santiago C; Kråkenes TA; Kleppe R; López-Blanco JR; Marcilla M; Teigen K; Alvira S; Chacón P; Martinez A; Valpuesta JM
    Nat Commun; 2022 Jan; 13(1):74. PubMed ID: 35013193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.